GSK Announces 2.2 Billion Dollar Acquisition of RAPT Therapeutics
GSK plc announced on January 20 that it will acquire US based RAPT Therapeutics for 2.2 billion dollars. The move aims to expand its therapeutic pipeline.
Insights:
GSK plc announced on January 20, 2026, that it has reached an agreement to acquire RAPT Therapeutics for a total of $2.2 billion. This transaction represents a significant capital deployment by GSK plcas part of its ongoing efforts to expand its therapeutic pipeline through the acquisition of a biotechnology company based in the United States 
US. The announcement was first reported by Reuters.
US. The announcement was first reported by Reuters.
